Aug. 27th, 2019

I reported to the IRS this morning, and they’re not sending me to Alcatraz. There may be further questions about my 2017 charitable donations, and perhaps some adjustment of the tax return, but no serious trouble. I was, I am happy to report, treated with friendliness and courtesy throughout, both by the experienced agent, and the trainee who is practicing his skills on me.

This is, despite the term I use as a tag, a tax Examination, not a full audit.

I still favor switching to land value taxation, so that this kind of thing would not be necessary, among other reasons.
A court in Oklahoma has ruled against Johnson & Johnson for manufacturing legal opiates, and making them available to patients with prescriptions. One may believe that we have an opioid abuse problem without approving of this verdict. I will leave to those more learned in the law the analysis of the legal issue; I will address the incentives and likely consequences that a ruling like this creates. It sends a message to pharmaceutical companies: Don’t make opiates, or at least be very careful not to make them excessively available, and impose, one presumes, rigorous controls on the physicians and pharmacies involved in putting them into the hands of patients.

This means that people in real and serious pain will in some cases be unable to obtain opiates legally, and will either suffer, or commit suicide, or turn to the black market; the same applies to those who are already addicted, however they became addicts. Black market heroin, fentanyl, or God-knows-what will vary in content, purity, and contaminants, so at least in some cases, people who turn to illegal sources of supply will suffer fatal overdoses, or other problems that would be unlikely to occur if they were buying oxycodone from their neighborhood pharmacist.

Thus, cracking down on opiates will (and already has) result in more deaths from opiate abuse. QED.

Profile

ndrosen

July 2025

S M T W T F S
  12 3 4 5
6789 1011 12
13 141516171819
20212223242526
2728293031  

Most Popular Tags

Style Credit

Expand Cut Tags

No cut tags
Page generated Jul. 14th, 2025 04:41 pm
Powered by Dreamwidth Studios